Prof Peter Crack
Professor
Department of Biochemistry and Pharmacology
120 Scholarly works
36 Projects
HIGHLIGHTS
2026
Journal article
Type I Interferons Drive the Gastrointestinal Inflammatory Response in a Mouse Model of Parkinson’s Disease
DOI: 10.1016/j.gastha.2026.1009292025
Journal article
The contribution of type-I IFN-mediated neuroinflammation to Parkinson's disease progression
DOI: 10.1016/j.bbih.2025.1010172025
Journal article
Generative AI and digital twins: shaping a paradigm shift from precision to truly personalized medicine
DOI: 10.1080/17460441.2025.25073762025
Thesis / Dissertation
Characterisation of the role of the type-I Interferons in the alpha-synuclein model of Parkinson's disease
2023
Research grants (other domestic)
Discovery of STING Inhibitors for the Treatment of MND
2019
Research Grant
Utilising Biomaterials to Harness Endogenous Neural Stem Cells for Brain Repair
2018
Research Grant
Understanding Neuroinflammation in Alzheimer's Disease
RECENT SCHOLARLY WORKS
2024
Journal article
IKKɛ induces STING non-IFN immune responses via a mechanism analogous to TBK1
DOI: 10.1016/j.isci.2024.1106932024
Journal article
Pharmacological inhibition of STING reduces neuroinflammation-mediated damage post-traumatic brain injury
DOI: 10.1111/bph.163472023
Journal article
ALTERATION OF NEUROIMMUNE PATHWAYS RESCUES IMPAIRED INTESTINAL PERMEABILITY AND BEHAVIOUR IN A MOUSE MODEL OF COLITIS
DOI: 10.1016/j.ibneur.2023.08.4952023
Conference Proceedings
iBalls: an updated and expanded iris simulator for teaching autonomic pharmacology and the utility of drugs in an ocular diagnostic setting
2022
Book Chapter
The Emerging Role of the Gut-Brain-Microbiota Axis in Neurodevelopmental Disorders.
DOI: 10.1007/978-3-031-05843-1_142021
Journal article
Biomaterial Strategies for Restorative Therapies in Parkinson's Disease
DOI: 10.1021/acschemneuro.1c004842021
Journal article
The Complexity of the cGAS-STING Pathway in CNS Pathologies
DOI: 10.3389/fnins.2021.621501
RECENT PROJECTS
2026
Research grants (ARC, NHMRC, MRFF)
Targeting STING in Treating Traumatic Brain Injury.